Levetimide

• Description :

  Levetimide is a potent and stereoselective inhibitor of [3H] (+) pentazocine binding, with a Ki of 2.2 nM[1].

• UNSPSC :

  12352005

• Target :

  MAChR

• Type :

  Reference compound

• Related Pathways :

  GPCR/G Protein; Neuronal Signaling

• Applications :

  Neuroscience-Neuromodulation

• Field of Research :

  Neurological Disease

• Assay Protocol :

  https://www.medchemexpress.com/levetimide.html

• Purity :

  99.96

• Solubility :

  DMSO : ≥ 100 mg/mL

• Smiles :

  O=C(N1)[C@](C2=CC=CC=C2)(CCC1=O)C3CCN(CC3)CC4=CC=CC=C4

• Molecular Formula :

  C23H26N2O2

• Molecular Weight :

  362.46

• References & Citations :

  [1]DeHaven-Hudkins DL, et al. Binding of dexetimide and levetimide to [3H] (+) pentazocine- and [3H]1,3-di (2-tolyl) guanidine-defined sigma recognition sites. Life Sci. 1991;49 (18) :PL135-9.

• Shipping Conditions :

  Room Temperature

• Storage Conditions :

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [21888-99-3]